https://www.fiercebiotech.com/biotech/imvax-raises-112m-to-advance-brain-cancer-cell-therapy
Imvax raises $112M to advance brain cancer cell therapy | Fierce Biotech
Jul 16, 2020 - Imvax has raised $112 million to take its autologous tumor cell vaccine into
brain cancercell therapyraisesadvance
https://theorg.com/org/imvax?person=john-m-limongelli
Imvax | The Org
Imvax is a clinical-stage biotechnology company with a unique immunotherapy approach to solid tumors.
https://www.fiercebiotech.com/biotech/imvax-takes-brain-cancer-cell-therapy-fda-betting-survival-hit-will-overshadow-primary-miss
Imvax takes brain cancer therapy to FDA despite missing primary
Dec 2, 2025 - Imvax shrugged off the failure to hit its primary endpoint, reporting evidence of improved overall survival and making a beeline for the FDA.
brain cancer therapytakesfdadespitemissing